One Study Down, Three To Go On Animas’ First-Gen Artificial Pancreas Project
This article was originally published in The Gray Sheet
Executive Summary
Following a successful feasibility study, the J&J unit still has multiple clinical milestones to hit before it can put its closed-loop diabetes treatment system up for market approval.